WANBURY
|
The Current P/S Ratio of WANBURY is 1.65.
Share Price | ₹300.3 | Jun 17,2025 |
Market Cap | ₹985.0 Cr | |
Sales-TTM | ₹597.8 Cr | TTM-Consolidated Results |
Price/Sales | 1.65x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WANBURY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹985.0 Cr] as on Jun 17,2025
(/) Sales [ ₹597.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.65x ]
Thus, for WANBURY , the investors are currently willing to pay '1.65 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WANBURY !
The chart below summarizes the trend in P/S Ratio of WANBURY over the last five years.
Historical PS (Price/Sales) ratio chart of WANBURY
PS Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.45x.
- WANBURY 's operated at median p/e ratio of 0.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 0.83x.
- WANBURY 's p/e ratio hit its five-year low in Mar2020 of 0.12x.
How does WANBURY 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WANBURY | 597.8 | 1.65 | 985.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.52 | 395,614.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.54 | 173,533.0 |
CIPLA LTD | 27,547.6 | 4.41 | 121,439.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.56 | 110,066.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.37 | 110,076.0 |
MANKIND PHARMA LTD | 12,279.3 | 7.91 | 97,090.3 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.15 | 96,487.8 |
LUPIN LTD | 22,707.9 | 3.91 | 88,756.5 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.03 | 64,439.9 |
ABBOTT INDIA LTD | 6,409.2 | 10.54 | 67,579.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WANBURY 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.65x |
Max industry PS | 18.54x |
Median industry PS | 4.41x |
Average industry PS | 6.69x |
You may also like the below Video Courses